202 related articles for article (PubMed ID: 19485899)
1. The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis.
Rico MC; Rough JJ; Del Carpio-Cano FE; Kunapuli SP; DeLa Cadena RA
Curr Vasc Pharmacol; 2010 May; 8(3):338-43. PubMed ID: 19485899
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis.
Rico MC; Manns JM; Driban JB; Uknis AB; Kunapuli SP; Dela Cadena RA
Transl Res; 2008 Aug; 152(2):95-8. PubMed ID: 18674744
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1-derived peptide treatment.
Rico MC; Castaneda JL; Manns JM; Uknis AB; Sainz IM; Safadi FF; Popoff SN; Dela Cadena RA
J Cell Physiol; 2007 May; 211(2):504-12. PubMed ID: 17219411
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis.
Miyashita T; Morimoto S; Fujishiro M; Hayakawa K; Suzuki S; Ikeda K; Miyazawa K; Morioka M; Takamori K; Ogawa H; Sekigawa I; Takasaki Y
Autoimmunity; 2016; 49(2):109-14. PubMed ID: 26584911
[TBL] [Abstract][Full Text] [Related]
5. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis.
Wu Y; Pan W; Hu X; Zhang A; Wei W
Biochem Pharmacol; 2021 Jan; 183():114360. PubMed ID: 33301760
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis.
Nozawa K; Fujishiro M; Kawasaki M; Kaneko H; Iwabuchi K; Yanagida M; Suzuki F; Miyazawa K; Takasaki Y; Ogawa H; Takamori K; Sekigawa I
Arthritis Res Ther; 2009; 11(6):R174. PubMed ID: 19922639
[TBL] [Abstract][Full Text] [Related]
7. Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomics study.
Wang JG; Xu WD; Zhai WT; Li Y; Hu JW; Hu B; Li M; Zhang L; Guo W; Zhang JP; Wang LH; Jiao BH
Arthritis Rheum; 2012 Apr; 64(4):993-1004. PubMed ID: 22006448
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor.
Rico MC; Rough JJ; Manns JM; Del Carpio-Cano F; Safadi FF; Kunapuli SP; DeLa Cadena RA
Thromb Res; 2012 Jun; 129(6):801-6. PubMed ID: 21889790
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic targets in rheumatoid arthritis.
Koenders MI; van den Berg WB
Trends Pharmacol Sci; 2015 Apr; 36(4):189-95. PubMed ID: 25732812
[TBL] [Abstract][Full Text] [Related]
10. A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor.
Manns JM; Uknis AB; Rico MC; Agelan A; Castaneda J; Arango I; Barbe MF; Safadi FF; Popoff SN; DeLa Cadena RA
Arthritis Rheum; 2006 Aug; 54(8):2415-22. PubMed ID: 16869004
[TBL] [Abstract][Full Text] [Related]
11. Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium.
Gotis-Graham I; Hogg PJ; McNeil HP
Arthritis Rheum; 1997 Oct; 40(10):1780-7. PubMed ID: 9336411
[TBL] [Abstract][Full Text] [Related]
12. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
[TBL] [Abstract][Full Text] [Related]
13. New potential therapeutic approaches targeting synovial fibroblasts in rheumatoid arthritis.
José Alcaraz M
Biochem Pharmacol; 2021 Dec; 194():114815. PubMed ID: 34715065
[TBL] [Abstract][Full Text] [Related]
14. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
Pohlers D; Beyer A; Koczan D; Wilhelm T; Thiesen HJ; Kinne RW
Arthritis Res Ther; 2007; 9(3):R59. PubMed ID: 17594488
[TBL] [Abstract][Full Text] [Related]
15. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology.
Leask A; Abraham DJ
Biochem Cell Biol; 2003 Dec; 81(6):355-63. PubMed ID: 14663501
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor-targeting DNA aptamer suppresses pannus formation as diagnostics and therapeutics for rheumatoid arthritis.
Wu G; Liu C; Cao B; Cao Z; Zhai H; Liu B; Jin S; Yang X; Lv C; Wang J
Front Immunol; 2022; 13():934061. PubMed ID: 35990694
[TBL] [Abstract][Full Text] [Related]
17. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.
Sonnylal S; Shi-Wen X; Leoni P; Naff K; Van Pelt CS; Nakamura H; Leask A; Abraham D; Bou-Gharios G; de Crombrugghe B
Arthritis Rheum; 2010 May; 62(5):1523-32. PubMed ID: 20213804
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor contributes to joint homeostasis and osteoarthritis severity by controlling the matrix sequestration and activation of latent TGFβ.
Tang X; Muhammad H; McLean C; Miotla-Zarebska J; Fleming J; Didangelos A; Önnerfjord P; Leask A; Saklatvala J; Vincent TL
Ann Rheum Dis; 2018 Sep; 77(9):1372-1380. PubMed ID: 29925506
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
Qi W; Chen X; Poronnik P; Pollock CA
Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
[TBL] [Abstract][Full Text] [Related]
20. Current understanding of rheumatoid arthritis therapy.
Colmegna I; Ohata BR; Menard HA
Clin Pharmacol Ther; 2012 Apr; 91(4):607-20. PubMed ID: 22357455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
